Original Article
Tolerability, safety, and preliminary antitumor activity of fuzuloparib in combination with SHR-1316 in patients with relapsed small cell lung cancer: a multicenter, open-label, two-stage, phase Ib trial
Yanjun Xu, Zhiyu Huang, Jian Fang, Anwen Liu, Hongyang Lu, Xinmin Yu, Kaiyan Chen, Xiaoling Xu, Xinjing Ma, Wei Shi, Young Hak Kim, Taiki Hakozaki, Alfredo Addeo, Yu Shen, Shaorong Li, Yun Fan